| 11/5/2025 | SP | New Issue: Scotiabank prices $3.21 million trigger autocallable gears linked to basket of stocks
|
| 4/29/2022 | SP | New Issue: GS Finance sells $9.25 million basket-linked notes tied to 77 stocks
|
| 12/14/2021 | SP | New Issue: JPMorgan sells $1.22 million trigger autocallable contingent yield notes on AstraZeneca
|
| 11/22/2021 | SP | New Issue: Citi prices $1.47 million autocallable contingent coupon equity notes on three stocks
|
| 8/26/2021 | SP | New Issue: GS Finance prices $13.14 million leveraged basket-linked notes on 179 stocks
|
| 2/9/2021 | SP | New Issue: Credit Suisse sells $1.4 million contingent coupon autocallables on pharma stocks
|
| 12/31/2020 | SP | New Issue: Credit Suisse sells $12.23 million contingent income autocalls on two pharma stocks
|
| 11/12/2020 | SP | New Issue: RBC prices $409,000 trigger autocallable contingent yield notes on AstraZeneca
|
| 9/18/2020 | SP | New Issue: Citi sells $1.7 million callable contingent coupon notes on three stocks
|
| 8/7/2020 | SP | New Issue: Citigroup sells $10 million equity-linked securities on three stocks
|
| 5/28/2019 | SP | Credit Suisse to price buffered return equity notes on stock basket
|
| 5/6/2019 | SP | Credit Suisse to price buffered return equity notes on stock basket
|
| 7/27/2017 | SP | New Issue: UBS prices $125,000 airbag yield optimization notes on AstraZeneca
|
| 6/26/2017 | SP | New Issue: UBS prices $1.06 million trigger phoenix autocallable optimization securities linked to AstraZeneca
|
| 5/19/2017 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallables linked to AstraZeneca
|
| 5/9/2017 | SP | New Issue: UBS prices $343,000 trigger phoenix autocallables linked to AstraZeneca
|
| 5/5/2017 | SP | New Issue: UBS prices $544,000 trigger phoenix autocallables linked to AstraZeneca
|
| 5/5/2017 | SP | New Issue: UBS prices $708,500 trigger phoenix autocallables linked to AstraZeneca
|
| 5/1/2017 | SP | New Issue: Citigroup prices $4.68 million contingent income autocallables linked to AstraZeneca
|
| 3/21/2017 | SP | New Issue: UBS prices $1.02 million trigger phoenix autocallables linked to AstraZeneca
|
| 12/27/2016 | SP | New Issue: UBS prices $425,000 trigger phoenix autocallables linked to AstraZeneca
|
| 12/21/2016 | SP | New Issue: UBS prices $230,000 trigger phoenix autocallables linked to AstraZeneca
|
| 12/19/2016 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallables linked to AstraZeneca
|
| 12/16/2016 | SP | New Issue: UBS prices $1.01 million trigger phoenix autocallable optimization securities linked to AstraZeneca
|
| 12/15/2016 | SP | New Issue: UBS prices $200,000 trigger phoenix autocallables linked to AstraZeneca
|
| 12/15/2016 | SP | New Issue: UBS prices $319,000 trigger phoenix autocallables linked to AstraZeneca
|
| 12/14/2016 | SP | New Issue: UBS prices $266,000 trigger phoenix autocallables linked to AstraZeneca
|
| 12/14/2016 | SP | New Issue: UBS prices $1.33 million trigger phoenix autocallables linked to AstraZeneca
|
| 12/14/2016 | SP | New Issue: UBS prices $280,000 trigger phoenix autocallables linked to AstraZeneca
|
| 10/7/2016 | SP | New Issue: RBC prices $6.47 million Accelerated Return Notes linked to pharma stocks
|
| 9/26/2016 | SP | RBC plans 14-month Accelerated Return Notes linked to pharma stocks
|
| 4/16/2015 | SP | New Issue: Barclays prices $1.38 million seven-year notes linked to basket of ADSs
|
| 8/29/2014 | SP | New Issue: Credit Suisse prices $550,000 contingent coupon autocallables linked to two stocks
|
| 8/19/2014 | SP | Credit Suisse plans contingent coupon autocallables tied to two stocks
|
| 7/31/2014 | SP | New Issue: Deutsche Bank prices $7.92 million trigger phoenix autocallables linked to AstraZeneca
|
| 7/23/2014 | SP | Deutsche Bank plans trigger phoenix autocallables tied to AstraZeneca
|
| 3/11/2014 | SP | New Issue: HSBC prices $7 million return enhanced notes linked to three stocks
|
| 3/5/2014 | SP | New Issue: HSBC prices $675,000 return enhanced notes linked to three stocks
|
| 2/27/2014 | SP | New Issue: HSBC prices $2.03 million return enhanced notes linked to three stocks
|
| 2/26/2014 | SP | HSBC plans three-year return enhanced notes linked to three stocks
|
| 2/24/2014 | SP | New Issue: HSBC prices $1.7 million return enhanced notes linked to pharma stocks
|
| 2/20/2014 | SP | HSBC plans three-year return enhanced notes linked to three stocks
|
| 2/20/2014 | SP | New Issue: HSBC prices $1.1 million knock-out buffer notes linked to basket of three stocks
|
| 2/20/2014 | SP | New Issue: HSBC prices $2.69 million return enhanced notes linked to three stocks
|
| 2/13/2014 | SP | HSBC to price knock-out buffer notes tied to basket of three stocks
|
| 2/11/2014 | SP | New Issue: Deutsche Bank prices $445,000 return enhanced notes linked to pharma stocks
|
| 2/11/2014 | SP | HSBC plans three-year return enhanced notes linked to three stocks
|
| 2/5/2014 | SP | New Issue: Deutsche Bank prices $1.26 million knock-out notes linked to three stocks
|
| 2/5/2014 | SP | New Issue: Deutsche Bank prices $4.23 million knock-out notes tied to three stocks
|
| 2/4/2014 | SP | New Issue: Deutsche Bank prices $3.42 million return enhanced notes linked to pharma stocks
|
| 1/29/2014 | SP | Deutsche Bank plans knock-out notes tied to basket of three stocks
|
| 3/8/2007 | SP | New Issue: ABN Amro prices $2.65 million 9% knock-in notes linked to Astrazeneca
|
| 3/5/2007 | SP | ABN Amro to price 9% reverse convertibles linked to Astrazeneca
|
